Ambryx

Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Fierce Biotech
Wed, 04/3/24 - 11:36 am
biotech
M&A
IPOs
CG Oncology
Kyverna Therapeutics
Contineum Therapeutics
Boundless Bio
CymaBay Therapeutics
Gilead Sciences
MorphoSys
Novartis
Fusion Pharmaceuticals
AstraZeneca
Ambryx
JNJ
Inhibrix
Aventis
Merck's $303 Million Ambryx Deal Great For Investors
Seeking Alpha
Thu, 06/28/12 - 06:03 pm
Merck
Ambryx
AstraZeneca
GSK
Novartis
Pfizer
Palatin